MEDICAL SYSTEM NETWORK Co., Ltd., The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 22% Decrease

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Oct 31, 2024 3:00 pm JST Revision

4350 MEDICAL SYSTEM NETWORK Co., Ltd. 【J-GAAP】

Guidance Update Report

MEDICAL SYSTEM NETWORK Co., Ltd. <4350> [TSE-S] announced a performance revision after the market closed on October 31st (15:00). The consolidated ordinary profit for the fiscal year ending March 2025 has downwardly by 24.1%, from the previous forecast of 3.95 billion yen to 3 billion yen (compared to 3.82 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 21.6% decrease in profit.

At the same time, the April to September period (first half) consolidated ordinary profit has downwardly by 35.8%, from the previous forecast of 1.59 billion yen to 1.02 billion yen (compared to 1.69 billion yen in the same period of the previous year), leading to an increase in the profit decline rate from 6.0% to 39.7%.

Kabutan News

Guidance Update

First Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Prev	59,500	1,600	1,590	785	26.9	6	May 10, 2024	J-GAAP
Apr - Sep, 2024 New	59,761	1,027	1,020	207	7.1	6	Oct 31, 2024	J-GAAP
Revision Rate	+0.4%	-35.8%	-35.8%	-73.6%	-73.6%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	122,000	4,000	3,950	2,000	68.4	12	May 10, 2024	J-GAAP
Mar, 2025 New	122,000	3,000	3,000	1,250	42.8	12	Oct 31, 2024	J-GAAP
Revision Rate	0.0%	-25.0%	-24.1%	-37.5%	-37.5%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2023	56,461	1,712	1,692	861	28.5	6	Nov 7, 2023	J-GAAP
Apr - Sep, 2024 Guidance	59,761	1,027	1,020	207	7.1	6	Oct 31, 2024	J-GAAP
YoY	+5.8%	-40.0%	-39.7%	-76.0%	-75.2%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	109,551	3,163	3,355	1,610	53.4	12	May 9, 2023	J-GAAP
Mar, 2024	115,361	3,832	3,825	1,860	61.9	12	May 10, 2024	J-GAAP
Mar, 2025 Guidance	122,000	3,000	3,000	1,250	42.8	12	Oct 31, 2024	J-GAAP
YoY	+5.8%	-21.7%	-21.6%	-32.8%	-30.9%